AAVantgarde Bio
Healthcare
HQ: Milan, Italy
Investors: 3
Clinical-stage biotechnology company developing gene therapies for inherited retinal diseases.
Investors (3)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Cdp Venture Capital | Current | - | - | Website |
| Neva SGR | Current | - | - | Website |
| Sofinnova Partners | Current | - | - | Website |
Get these signals delivered weekly
Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.
Get Signals